REGISTER HERE in person & online registration options - this link will take you to the ticketing site Humanitix
PROGRAM NOW AVAILABLE please be aware that the program can change at anytime without notice
Program committee
Prof Jon Iredell Senior Staff Specialist Westmead Hospital, Director Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Professor of Medicine and Microbiology, University of Sydney
Dr Holly Sinclair Advanced Therapeutics Fellow, Westmead Hospital
A/Prof Ameneh Khatami Paediatric Infectious Diseases Specialist, Westmead Children’s Hospital, Associate Professor, Discipline of Child and Adolescent Health, Children's Hospital at Westmead Clinical School
This practically oriented one-day course is designed for those prescribing bacteriophage therapy or considering doing so. Sessions will cover diagnostics (with a strong emphasis on genomics), quality assurance and batch production assessments and dispensing, clinical trial and regulatory aspects, current experience in regard to pharmacokinetics and pharmacodynamics, clinical experience with phage therapy in humans and the co-adaptation of phages and bacteria in vivo.
The course is designed to support doctors, nurses and pharmacists by providing the necessary knowledge base for safe delivery of therapeutic phages. The faculty includes clinicians with extensive hands-on experience in adult and paediatric medicine and will be delivered on line and in person at Westmead.
Confirmed Speakers include;
Prof Robert Edwards, Matthew Flinders Fellow in Bioinformatics at Flinders University, Adelaide SA
Prof Morgyn Warner, Clinical Director of Microbiology and Infectious Diseases at SA Pathology
Dr Kerry Watts, Senior Project and Policy Officer, Advanced Therapeutics, Office for Health and Medical Research (MoH)
Please check out the program above for a comprehensive list of esteemed speakers presenting at the course
Sessions will include;
Biology & Biotech
Basic PK/PD, receptors, defences and adaptations
From diagnostics to production QC
High-throughput genomics for advanced therapeutics
Practical bioinformatics for phage therapy
Delivering phage therapy
Health Economics/ SROI
Biobanking and GMP
NSW pharmacy and TGA guidelines
Handling GMO phages: a Pharmacy perspective
Phage delivery at home and in hospital
Inflammatory responses
Clinical experience
Current experience, including QAMH, STAMP
staph aureus: ABSA01, diSArm
pseudomonal infection, incl. CF and non-CF
Case 4: (CM42) in vivo evolution
STAMP 2.0, SABRE Phi and future trials